Spyre Therapeutics (SYRE) Gains from Investment Securities (2015 - 2024)
Spyre Therapeutics posted quarterly Gains from Investment Securities of -$200000.0 for Q2 2024, down 100.32% year-on-year from $63.4 million in Q3 2023, and up 78.0% on a QoQ basis from -$909000.0 in Q3 2023.
Spyre Therapeutics (SYRE) has 10 years of Gains from Investment Securities data on file, last reported at -$200000.0 in Q2 2024.
- For the quarter ending Q2 2024, Gains from Investment Securities fell 100.32% year-over-year to -$200000.0; the trailing twelve-month figure through Dec 2024 stood at -$200000.0 (down 29.87% YoY), and the FY2023 full-year result was -$915000.0, down 109.04% from the prior year.
- Gains from Investment Securities for Q2 2024 stood at -$200000.0, up from -$909000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $63.4 million in Q2 2023 and bottomed at -$909000.0 in Q3 2023.
- The 5-year median for Gains from Investment Securities is $366600.0 (2021), against an average of $4.8 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities soared 42760.0%; it then slumped 123.66% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at -$14000.0 in 2020, then jumped by 2507.14% to $337000.0 in 2021, then rose by 24.04% to $418000.0 in 2022, then sank by 317.46% to -$909000.0 in 2023, then jumped by 78.0% to -$200000.0 in 2024.
- The last three Gains from Investment Securities figures came in at -$200000.0 (Q2 2024), -$909000.0 (Q3 2023), and $63.4 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -200,000.00 |
| Jun 30, 2024 | -200,000.00 |
| Sep 30, 2023 | -909,000.00 |
| Sep 30, 2023 | -909,000.00 |
| Jun 30, 2023 | 63.42 Mn |
| Jun 30, 2023 | 63.42 Mn |
| Mar 31, 2023 | 4.44 Mn |
| Mar 31, 2023 | 4.44 Mn |
| Dec 31, 2022 | 418,000.00 |
| Dec 31, 2022 | 418,000.00 |
| Sep 30, 2022 | 3.84 Mn |
| Sep 30, 2022 | 3.84 Mn |
| Jun 30, 2022 | 429,000.00 |
| Jun 30, 2022 | 429,000.00 |
| Mar 31, 2022 | 2.14 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 337,000.00 |
| Dec 31, 2021 | 337,000.00 |
| Sep 30, 2021 | 396,200.00 |
| Sep 30, 2021 | 396,200.00 |
| Jun 30, 2021 | 2.16 Mn |
| Jun 30, 2021 | 2.16 Mn |
| Mar 31, 2021 | 5,000.00 |
| Mar 31, 2021 | 5,000.00 |
| Dec 31, 2020 | -14,000.00 |
| Dec 31, 2020 | -14,000.00 |
| Sep 30, 2020 | 228,200.00 |
| Sep 30, 2020 | 228,200.00 |
| Jun 30, 2020 | 239,400.00 |
| Jun 30, 2020 | 239,400.00 |
| Mar 31, 2020 | 7,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Dec 31, 2019 | -18,000.00 |
| Dec 31, 2019 | -18,000.00 |
| Sep 30, 2019 | 44,000.00 |
| Sep 30, 2019 | 44,000.00 |
| Jun 30, 2019 | 1.20 Mn |
| Jun 30, 2019 | 1.20 Mn |
| Mar 31, 2019 | 6,000.00 |
| Mar 31, 2019 | 6,000.00 |
| Dec 31, 2018 | -30,000.00 |
| Dec 31, 2018 | -30,000.00 |
| Sep 30, 2018 | 1.29 Mn |
| Sep 30, 2018 | 1.29 Mn |
| Jun 30, 2018 | 203,600.00 |
| Jun 30, 2018 | 203,600.00 |
| Mar 31, 2018 | 829,500.00 |
| Mar 31, 2018 | 829,500.00 |
| Dec 31, 2017 | -15,000.00 |
| Dec 31, 2017 | -15,000.00 |
| Sep 30, 2017 | 735,600.00 |
| Sep 30, 2017 | 735,600.00 |
| Jun 30, 2017 | 244,100.00 |
| Jun 30, 2017 | 244,100.00 |
| Mar 31, 2017 | 772,800.00 |
| Mar 31, 2017 | 772,800.00 |
| Dec 31, 2016 | -6,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Sep 30, 2016 | 11,562.00 |
| Sep 30, 2016 | 11,562.00 |
| Jun 30, 2016 | 720,217.00 |
| Jun 30, 2016 | 720,217.00 |
| Mar 31, 2016 | 84,417.00 |
| Mar 31, 2016 | 84,417.00 |
| Dec 31, 2015 | 21,000.00 |
| Dec 31, 2015 | 21,000.00 |
| Sep 30, 2015 | 644,505.00 |
| Sep 30, 2015 | 644,505.00 |
| Jun 30, 2015 | 544,059.00 |
| Jun 30, 2015 | 544,059.00 |
| Mar 31, 2015 | -2,000.00 |
| Mar 31, 2015 | -2,000.00 |